Correlation Between Adaptimmune Therapeutics and Affimed NV
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Affimed NV, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Affimed NV.
Diversification Opportunities for Adaptimmune Therapeutics and Affimed NV
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptimmune and Affimed is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Affimed NV go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Affimed NV
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Affimed NV. In addition to that, Adaptimmune Therapeutics is 1.22 times more volatile than Affimed NV. It trades about -0.21 of its total potential returns per unit of risk. Affimed NV is currently generating about -0.18 per unit of volatility. If you would invest 420.00 in Affimed NV on August 26, 2024 and sell it today you would lose (158.00) from holding Affimed NV or give up 37.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Affimed NV
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Affimed NV |
Adaptimmune Therapeutics and Affimed NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Affimed NV
The main advantage of trading using opposite Adaptimmune Therapeutics and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.The idea behind Adaptimmune Therapeutics Plc and Affimed NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Affimed NV vs. Eliem Therapeutics | Affimed NV vs. HCW Biologics | Affimed NV vs. Scpharmaceuticals | Affimed NV vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |